Effect of alcohol on diethylnitrosamine-induced hepatic toxicity: Critical role of ROS, lipid accumulation, and mitochondrial dysfunction

Bartsch, 1984, Relevance of nitrosoamines to human cancer, Carcinogenesis, 5, 1381, 10.1093/carcin/5.11.1381 Bosetti, 2014, Hepatocellular carcinoma epidemiology, Best Pract. Res. Clin. Gastroenterol., 28, 753, 10.1016/j.bpg.2014.08.007 Coussens, 2002, Inflammation and cancer, Nature, 420, 860, 10.1038/nature01322 Fausto, 2010, Mouse models of hepatocellular carcinoma, Semin Liver Dis., 30, 87, 10.1055/s-0030-1247135 Hassan, 2002, Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus, Hepatology, 36, 1206, 10.1053/jhep.2002.36780 Isse, 2005, Aldehyde dehydrogenase 2 gene targeting mouse lacking enzyme activity show high acetaldehyde level in blood, brain, and liver after ethanol gavages, Alcohol Clin. Exp. Res., 29, 1959, 10.1097/01.alc.0000187161.07820.21 Lauren, 1990, Cytotoxicity phase of diethylnitrosamine-induced hepatic neoplasia in medaka, Cancer Res., 50, 5504 Lee, 2004, Application of comparative functional genomics to identify best-fit mouse models to study human cancer, Nat. Genet., 36, 1306, 10.1038/ng1481 Lieber, 1998, Metabolism of ethanol and some associated adverse effects on the liver and the stomach, Recent Dev. Alcohol, 14, 7, 10.1007/0-306-47148-5_2 Llovet, 2003, Hepatocellular carcinoma, Lancet, 362, 1907, 10.1016/S0140-6736(03)14964-1 Loomba, 2010, Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men, Clin. Gastroenterol. Hepatol., 8, 891, 10.1016/j.cgh.2010.06.027 Loomba, 2013, Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study, Am. J. Epidemiol., 177, 333, 10.1093/aje/kws252 McKillop, 2005, Alcohol and liver cancer, Alcohol, 35, 195, 10.1016/j.alcohol.2005.04.004 McKillop, 2009, Role of alcohol in liver carcinogenesis, Semin Liver Dis., 29, 222, 10.1055/s-0029-1214377 Morgan, 2004, Alcohol and hepatocellular carcinoma, Gastroenterology, 127, S87, 10.1053/j.gastro.2004.09.020 Morgan, 2004, Alcohol and hepatocellular carcinoma, Gastroenterology, 127, S87, 10.1053/j.gastro.2004.09.020 Naugler, 2007, Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production, Science, 317, 121, 10.1126/science.1140485 Purohit, 2013, Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma, Life Sci., 92, 3, 10.1016/j.lfs.2012.10.009 Shibata, 1986, The role of drinking and cigarette smoking in the excess deaths from liver cancer, Jpn. J. Cancer Res., 77, 287 Sun, 2014, The therapeutic value of targeting inflammation in gastrointestinal cancers, Trends Pharmacol. Sci., 35, 349, 10.1016/j.tips.2014.04.011 Wang, 2013, Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects, Mol. Cell. Endocrinol., 376, 70, 10.1016/j.mce.2013.06.014 Williams, 1996, Diethylnitrosamine exposure-responses for DNA damage, centrilobular cytotoxicity, cell proliferation and carcinogenesis in rat liver exhibit some non-linearities, Carcinogenesis, 17, 2253, 10.1093/carcin/17.10.2253 Williams, 2000, Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine, Toxicol. Pathol., 28, 388, 10.1177/019262330002800306 Zhao, 2015, Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway, Cell Death Dis., 6, e1751, 10.1038/cddis.2015.120